As a disease of poverty, tuberculosis (TB) is claiming 1.5 million lives each year in lower-income countries throughout our region and the world. Given Results’ overarching mission to end global poverty, and our experience and reputation for impactful global health advocacy, TB is a natural focal point for our campaigning activities.
TB is one of the world’s deadliest infectious diseases, often devastating poor and marginalized communities. It is an airborne disease caused by bacteria that primarily affects the lungs and has plagued humanity for millenia. Over the past two centuries, TB has killed more than one billion people. Remarkably, we can end TB within a decade. To do this, we must support countries to diagnose and treat the disease effectively.
Our TB campaigns have often focused on the Global Fund to Fight AIDS, Tuberculosis and Malaria, as this respected public-private partnership provides 77% of all international TB financing. Our first major success with the Global Fund was in 2008-09, when our support and government outreach were acknowledged by the Global Fund as key factors leading to Australia’s participation in the Debt2Health Initiative, which resulted in millions of dollars being directed to domestic TB programs in Indonesia.
The impact of the Global Fund:
Results has since been a leading player in the Global Fund’s triennial replenishment events. Supported by our national network of volunteer advocates, and aligned civil society partners domestically and globally, we work to raise awareness of the burden of TB in the Indo-Pacific region and encourage Australia to contribute its fair share to the Global Fund. Since our involvement began, the Australian government’s pledges have increased from $135 million for the Third Replenishment (2008-10) to $242 million for the Sixth Replenishment (2019-22). With the Seventh Replenishment scheduled for 19th-21st September of this year, we are in the middle of a spirited campaign to encourage ministers and parliamentarians to support a new $450 million pledge to the Global Fund.
This proven track record of increased investment has only been made possible by our advocacy work to raise the profile of TB in Australia. Results is secretariat to the Australian TB Caucus (launched in 2016), a cross-partisan parliamentary friendship group. The Caucus brings together members of the House of Representatives and Senators keen to champion support and expertise for the global eradication of TB. The Caucus focuses on the Asia-Pacific region and increasing awareness about TB and its impact.